Leukemia  >>  Iomab-B (I-131-apamistamab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Iomab-B (I-131-apamistamab) / Actinium, Immedica
SIERRA, NCT02665065: Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

Checkmark Top line data from SIERRA trial for r/r AML
Oct 2022 - Oct 2022: Top line data from SIERRA trial for r/r AML
Checkmark Data from SIERRA trial for r/r AML
Apr 2022 - Apr 2022: Data from SIERRA trial for r/r AML
Checkmark Patient enrollment completed in P3 SIERRA trial for AML
More
Active, not recruiting
3
153
Canada, US
Iomab-B, Conventional Care, HCT
Actinium Pharmaceuticals
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute, Leukemia, Myeloid, Acute, Acute Myelogenous Leukemia, Leukemia, Acute Myelogenous, Myelogenous Leukemia, Acute, AML, Bone Marrow Transplant
06/22
12/26

Download Options